These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 2940974)

  • 1. Tissue penetration of ciprofloxacin after single and multiple doses.
    LeBel M; Vallée F; Bergeron MG
    Antimicrob Agents Chemother; 1986 Mar; 29(3):501-5. PubMed ID: 2940974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics and tissue penetration of ciprofloxacin.
    Crump B; Wise R; Dent J
    Antimicrob Agents Chemother; 1983 Nov; 24(5):784-6. PubMed ID: 6660852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of intravenously administered ciprofloxacin.
    Wise R; Lockley RM; Webberly M; Dent J
    Antimicrob Agents Chemother; 1984 Aug; 26(2):208-10. PubMed ID: 6486762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics and tissue penetration of fleroxacin after single and multiple 400- and 800-mg-dosage regimens.
    Panneton AC; Bergeron MG; LeBel M
    Antimicrob Agents Chemother; 1988 Oct; 32(10):1515-20. PubMed ID: 3142338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The comparative pharmacokinetics and tissue penetration of single-dose ciprofloxacin 400 mg i.v. and 750 mg po.
    Catchpole C; Andrews JM; Woodcock J; Wise R
    J Antimicrob Chemother; 1994 Jan; 33(1):103-10. PubMed ID: 8157550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Difference in blister fluid penetration after single and multiple doses of ceftriaxone.
    LeBel M; Grégoire S; Caron M; Bergeron MG
    Antimicrob Agents Chemother; 1985 Jul; 28(1):123-7. PubMed ID: 4037771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pharmacology of orally administered ciprofloxacin.
    Brittain DC; Scully BE; McElrath MJ; Steinman R; Labthavikul P; Neu HC
    Drugs Exp Clin Res; 1985; 11(5):339-41. PubMed ID: 2941262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple-dose pharmacokinetics and safety of ciprofloxacin in normal volunteers.
    Gonzalez MA; Uribe F; Moisen SD; Fuster AP; Selen A; Welling PG; Painter B
    Antimicrob Agents Chemother; 1984 Nov; 26(5):741-4. PubMed ID: 6517556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple-dose ciprofloxacin kinetics in normal subjects.
    Aronoff GE; Kenner CH; Sloan RS; Pottratz ST
    Clin Pharmacol Ther; 1984 Sep; 36(3):384-8. PubMed ID: 6467798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple-dose pharmacokinetics of ciprofloxacin administered intravenously to normal volunteers.
    Gonzalez MA; Moranchel AH; Duran S; Pichardo A; Magana JL; Painter B; Forrest A; Drusano GL
    Antimicrob Agents Chemother; 1985 Aug; 28(2):235-9. PubMed ID: 2939794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single-dose pharmacokinetics of oral ciprofloxacin in patients with cystic fibrosis.
    Goldfarb J; Wormser GP; Inchiosa MA; Guideri G; Diaz M; Gandhi R; Goltzman C; Mascia AV
    J Clin Pharmacol; 1986 Mar; 26(3):222-6. PubMed ID: 2937812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of ciprofloxacin after intravenous and increasing oral doses.
    Bergan T; Thorsteinsson SB; Kolstad IM; Johnsen S
    Eur J Clin Microbiol; 1986 Apr; 5(2):187-92. PubMed ID: 2941278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of ciprofloxacin in elderly subjects.
    LeBel M; Barbeau G; Bergeron MG; Roy D; Vallée F
    Pharmacotherapy; 1986; 6(2):87-91. PubMed ID: 2940518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics and tolerance of ciprofloxacin after sequential increasing oral doses.
    Tartaglione TA; Raffalovich AC; Poynor WJ; Espinel-Ingroff A; Kerkering TM
    Antimicrob Agents Chemother; 1986 Jan; 29(1):62-6. PubMed ID: 2942101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of three oral formulations of ciprofloxacin.
    Davis RL; Koup JR; Williams-Warren J; Weber A; Smith AL
    Antimicrob Agents Chemother; 1985 Jul; 28(1):74-7. PubMed ID: 2931047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum and tissue cage fluid concentrations of ciprofloxacin after oral administration of the drug to healthy dogs.
    Walker RD; Stein GE; Hauptman JG; MacDonald KH; Budsberg SC; Rosser EJ
    Am J Vet Res; 1990 Jun; 51(6):896-900. PubMed ID: 2195927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple-dose ciprofloxacin dose ranging and kinetics.
    Gonzalez MA; Moranchel AH; Duran S; Pichardo A; Magana JL; Painter B; Drusano GL
    Clin Pharmacol Ther; 1985 Jun; 37(6):633-7. PubMed ID: 3159530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics and pharmacodynamics of ciprofloxacin in cystic fibrosis patients.
    LeBel M; Bergeron MG; Vallée F; Fiset C; Chassé G; Bigonesse P; Rivard G
    Antimicrob Agents Chemother; 1986 Aug; 30(2):260-6. PubMed ID: 3094438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cefodizime penetration into skin suction blister fluid following a single intravenous dose.
    Schäfer-Korting M; Korting HC; Maass L; Klesel N; Grigoleit HG; Mutschler E
    Eur J Clin Pharmacol; 1986; 30(3):295-8. PubMed ID: 3732363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of standard breakfast on drug absorption and multiple-dose pharmacokinetics of ciprofloxacin.
    Ledergerber B; Bettex JD; Joos B; Flepp M; Lüthy R
    Antimicrob Agents Chemother; 1985 Mar; 27(3):350-2. PubMed ID: 3158273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.